Xavier Duportet
Xavier Duportet
Affiliation inconnue
Adresse e-mail validée de eligo-bioscience.com
Titre
Citée par
Citée par
Année
Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials
D Bikard, CW Euler, W Jiang, PM Nussenzweig, GW Goldberg, X Duportet, ...
Nature biotechnology 32 (11), 1146-1150, 2014
5682014
A platform for rapid prototyping of synthetic gene networks in mammalian cells
X Duportet, L Wroblewska, P Guye, Y Li, J Eyquem, J Rieders, T Rimchala, ...
Nucleic acids research 42 (21), 13440-13451, 2014
972014
The biological interpretation of metabolomic data can be misled by the extraction method used
X Duportet, RBM Aggio, S Carneiro, SG Villas-Bôas
Metabolomics 8 (3), 410-421, 2012
942012
Rapid, modular and reliable construction of complex mammalian gene circuits
P Guye, Y Li, L Wroblewska, X Duportet, R Weiss
Nucleic acids research 41 (16), e156-e156, 2013
892013
Development of sequence-specific antimicrobials based on programmable CRISPR-Cas nucleases
D Bikard, C Euler, W Jiang, PM Nussenzweig, GW Goldberg, X Duportet, ...
Nature biotechnology 32 (11), 1146, 2014
322014
Design and connection of robust genetic circuits
A Randall, P Guye, S Gupta, X Duportet, R Weiss
Methods in enzymology 497, 159-186, 2011
292011
Improving sequence-specific antimicrobials by blocking dna repair
D Bikard, CUI Lun, X Duportet, JF Rodriguez
202017
Comparison of integrases identifies Bxb1-GA mutant as the most efficient site-specific integrase system in mammalian cells
B Jusiak, K Jagtap, L Gaidukov, X Duportet, K Bandara, J Chu, L Zhang, ...
ACS synthetic biology 8 (1), 16-24, 2019
112019
Optimized vector for delivery in microbial populations
A Decrulle, JF Rodriguez, X Duportet, D Bikard
US Patent 10,808,254, 2020
22020
Developing new tools and platforms for mammalian synthetic biology: From the assembly and chromosomal integration of complex DNA circuits to the engineering of artificial …
X Duportet
Université Paris Diderot (Paris 7), 2014
22014
Optimized vector for delivery in microbial populations
A Decrulle, JF Rodriguez, X Duportet, D Bikard
US Patent App. 17/017,111, 2020
2020
Transcriptional control in prokaryotic cells using dna-binding repressors
JF Rodriguez, A Krawczyk, X Duportet
US Patent App. 16/819,935, 2020
2020
Optimized vector for delivery in microbial populations
A Decrulle, JF Rodriguez, X Duportet, D Bikard
US Patent App. 16/482,458, 2020
2020
Recombinases and target sequences
R Weiss, XC Duportet, G Batt, Y Li
US Patent 10,731,153, 2020
2020
SEQUENCE-SPECIFIC ANTIMICROBIALS BY BLOCKING DNA REPAIR
D Bikard, L Cui, X Duportet, J Fernandez Rodriguez
US Patent App. 16/671,978, 2020
2020
Bacterial delivery vehicle, process of production and uses thereof
A Decrulle, X Duportet, I Stzepourginski
US Patent App. 16/444,576, 2019
2019
Novel recombinases and target sequences
R Weiss, XC DUPORTET, B Gregory, LI Yinqing
2017
The biological interpretation of metabolomic data can be misled by the extraction method used
SG Villas-Bôas, X Duportet, S Carneiro, RBM Aggio
2011
Is the biological interpretation of metabolomic data misled by the extraction method performed?
X Duportet, SG Villas-Bôas, RBM Aggio, S Carneiro
New Biotechnology, S335-S336, 2009
2009
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–19